{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:19:27Z","timestamp":1790252367295,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"am","delay-in-days":257,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.rvsc.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T10:53:48Z","timestamp":1641552828000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus"],"prefix":"10.1016","volume":"144","author":[{"given":"Tomoyoshi","family":"Doki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2022.01.005_bb0005","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1099\/vir.0.19129-0","article-title":"Persistence and transmission of natural type I feline coronavirus infection","volume":"84","author":"Addie","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0010","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2015294","article-title":"Interferon Beta-1b and lopinavir\u2013ritonavir for middle east respiratory syndrome","volume":"383","author":"Arabi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.02240218","article-title":"Clinical pharmacology in HIV therapy","volume":"14","author":"Atta","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2460\/ajvr.1997.58.08.872","article-title":"Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats","volume":"58","author":"Boothe","year":"1997","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.synres.2014.07.003","article-title":"Frequently asked questions in drug combinations and the mass-action law-based answers","author":"Chou","year":"2014","journal-title":"Synergy"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0050","author":"ComboSyn Inc."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0055","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jvim.15780","article-title":"Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis","volume":"34","author":"Dickinson","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0065","article-title":"Therapeutic effect of an anti-human-TNF-alpha antibody and itraconazole on feline infectious peritonitis","volume":"1\u201310","author":"Doki","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0075","doi-asserted-by":"crossref","DOI":"10.7150\/thno.48342","article-title":"Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1292\/jvms.54.557","article-title":"The prevalence of types I and II feline coronavirus infections in cats","volume":"54","author":"Hohdatsu","year":"1992","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2010.06.010","article-title":"Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus","volume":"88","author":"Hsieh","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0090","series-title":"Virus Taxonomy: 2019 Release [WWW Document]","author":"ICTV","year":"2019"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virol.2017.12.027","article-title":"Feline coronavirus: insights into viral pathogenesis based on the spike protein structure and function","volume":"517","author":"Jaimes","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1292\/jvms.20-0049","article-title":"Clinical efficacy of combination therapy of itraconazole and prednisolone for treating effusive feline infectious peritonitis","volume":"82","author":"Kameshima","year":"2020","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0105","article-title":"Treatment of hepatitis C a systematic review","author":"Kohli","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0110","first-page":"1209","article-title":"Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland","volume":"12","author":"Kummrow","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.vetmic.2008.11.010","article-title":"Genetic diversity and correlation with feline infectious peritonitis of feline coronavirus type I and II: a 5-year study in Taiwan","volume":"136","author":"Lin","year":"2009","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0120","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.42.7.1738","article-title":"P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier","volume":"42","author":"Miyama","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tvjl.2014.04.017","article-title":"An update on feline infectious peritonitis: virology and immunopathogenesis","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis","volume":"21","author":"Pedersen","year":"2019","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.puhe.2016.05.004","article-title":"Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis","author":"Poorolajal","year":"2016","journal-title":"Public Health"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/s12248-020-00459-8","article-title":"Remdesivir for treatment of COVID-19: combination of pulmonary and IV administration may offer aditional benefit","volume":"22","author":"Sun","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0160","series-title":"Pharmacologic Treatment of SARS: Current Knowledge and Recommendations","author":"Tai","year":"2007"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.antiviral.2017.07.022","article-title":"The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection","volume":"145","author":"Takano","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-019-0625-3","article-title":"Antiviral activity of itraconazole against type i feline coronavirus infection","volume":"50","author":"Takano","year":"2019","journal-title":"Vet. Res."},{"key":"10.1016\/j.rvsc.2022.01.005_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8040300","article-title":"Endocytic pathway of feline coronavirus for cell entry: differences in serotype-dependent viral entry pathway","volume":"8","author":"Takano","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0180","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.aivir.2016.08.002","article-title":"Feline coronaviruses: pathogenesis of feline infectious peritonitis","author":"Tekes","year":"2016"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0185","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.apsb.2021.03.028","article-title":"Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment","volume":"11","author":"Xie","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.rvsc.2022.01.005_bb0190","article-title":"Pharmacokinetics of orally administered GS-441524 in dogs","author":"Yan","year":"2021","journal-title":"bioRxiv"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528822000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528822000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:25:19Z","timestamp":1758515119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528822000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"alternative-id":["S0034528822000145"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2022.01.005","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}